Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis

Stem Cells Translational Medicine

Volumn 2, Issue 3, 2013, Pages 167-174

  Popescu, Iuliana Ristea ^a   Nicaise, Charles ^a   Liu, Song ^b   Bisch, Grégoire ^c   Knippenberg, Sarah ^d   Daubie, Valery ^a   Bohl, Delphine ^c   Pochet, Roland ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Universite Paris Sud   (France)

^c INSTITUT PASTEUR   (France)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Neural differentiation; Neural stem cell; Neurons; Rat model; Spinal cord injury; Stem cell transplantation

Indexed keywords

ALPHA SYNUCLEIN; CYCLOSPORIN A; GLIAL FIBRILLARY ACIDIC PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MITOCHONDRION; MOUSE; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; RAT; SURVIVAL;

EID: 84875104910     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0042     Document Type: Article

References (36)

1. Mitchell JD, Borasio GD. Concise review: Amyotrophic lateral sclerosis. Lancet 2007; 369:2031-2041.
2. Cheah BC, Vucic S, Krishnan AV et al. Concise review: Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem 2010;17:1942-1999.
3. Wijesekera LC, Leigh PN. Concise review: Amyotrophic lateral sclerosis. Orphanet J Rare Dis 2009;4:3.
4. Rosen DR, Siddique T, Patterson D et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
5. Traub R, Mitsumoto H, Rowland L. Concise review: Research advances in amyotrophic lateral sclerosis, 2009 to 2010. Curr Neurol Neurosci Rep 2011;11:67-77.
6. Lindvall O, Kokaia Z. Concise review: Stem cells in human neurodegenerative disorders: Time for clinical translation? J Clin Invest 2010; 120:29-40.
7. Thonhoff JR, Ojeda L, Wu P. Concise review: Stem cell-derived motor neurons: Applications and challenges in amyotrophic lateral sclerosis. Curr Stem Cell Res Ther 2009;4:178-199.
8. Mitrecić D, Nicaise C, Gajović S et al. Distribution, differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis. Cell Transpl 2010;19:537-548.
9. Durnaoglu S, Genc S, Genc K. Concise review: Specific pluripotent stem cells in neurological diseases. Stem Cells Int 2011;2011: 212487.
10. Dimos JT, Rodolfa KT, Niakan KK et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008;321: 1218-1221.
11. Karumbayaram S, Novitch BG, Patterson M et al. Directed differentiation of human- induced pluripotent stem cells generates active motor neurons. STEM CELLS 2009; 27:806-811.
12. Ebert AD, Yu J, Rose FF, Jr., et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009;457: 277-280.
13. Mitne-Neto M, Machado-Costa M, Marchetto MC et al. Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum Mol Genet 2011;20:3642-3652.
14. Xu L, Tan YY, Ding JQ et al. Concise review: The iPs technique provides hope for Parkinson's disease treatment. Stem Cell Rev 2010;6:398-404.
15. Bilican B, Serio A, Barmada SJ et al. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci USA 2012;109:5803-5808.
16. Egawa N, Kitaoka S, Tsukita K et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med 2012;4:145ra104.
17. Lemonnier T, Blanchard S, Toli D et al. Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells. Hum Mol Genet 2011;20:3653-3666.
18. Brion JP, Guilleminot J, Couchie D et al. Both adult and juvenile tau microtubule-associated proteins are axon specific in the developing and adult rat cerebellum. Neuroscience 1988;25:139-146.
19. Bellin M, Marchetto MC, Gage FH et al. Induced pluripotent stem cells: The new patient? Nat Rev Mol Cell Biol 2012;13:713-726.
20. Park IH, Arora N, Huo H et al. Diseasespecific induced pluripotent stem cells. Cell 2008;134:877-886.
21. Baker M. Neurons from reprogrammed cells. Nat Methods 2011;8:905-909.
22. Rhee YH, Ko JY, Chang MY et al. Proteinbased human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J Clin Invest 2011;121:2326-2335.
23. Cai J, Yang M, Poremsky E et al. Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats. Stem Cells Dev 2010;19:1017-1023.
24. Hargus G, Cooper O, Deleidi M et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci USA 2010;107: 15921-15926.
25. Kriks S, Shim JW, Piao J et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011;480:547-551.
26. Swistowski A, Peng J, Liu Q et al. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. STEM CELLS 2010; 28:1893-1904.
27. Yan J, Xu L, Welsh AM et al. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. STEM CELLS 2006;24:1976-1985.
28. Xu L, Yan J, Chen D et al. Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation 2006;82:865-875.
29. Wyatt TJ, Rossi SL, Siegenthaler MM et al. Human motor neuron progenitor transplantation leads to endogenous neuronal sparing in 3 models of motor neuron loss. Stem Cells Int 2011;2011:207230.
30. Mothe AJ, Zahir T, Santaguida C et al. Neural stem/progenitor cells from the adult human spinal cord are multipotent and selfrenewing and differentiate after transplantation. PLoS One 2011;6:e27079.
31. Lepore AC, O'Donnell J, Kim AS et al. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. PLoS One 2011;6:e25968.
32. Howland DS, Liu J, She Y et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci USA 2002;99:1604-1609.
33. Nicaise C, Mitrecic D, Demetter P et al. Impaired blood- brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res 2009;1301:152-162.
34. Isacson O, Deacon TW, Pakzaban P et al. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nat Med 1995;1:1189-1194.
35. Trujillo CA, Negraes PD, Schwindt TT et al. Kinin-b2 receptor activity determines the differentiation fate of neural stem cells. J Biol Chem 2012;287:44046-44061.
36. Knippenberg S, Thau N, Schwabe K et al. Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener Dis 2012;9: 107-120.